The Arnold & Itkin Roundup lawsuit is one of the most significant ongoing mass tort battles in the United States. Thousands of people who used Roundup weedkiller have been diagnosed with non-Hodgkin’s lymphoma, and many are seeking compensation from Bayer AG, the company that acquired Monsanto in 2018.
Arnold & Itkin LLP is among the law firms representing plaintiffs in these cases. If you or someone you love used Roundup and later got a cancer diagnosis, what happens next and how much you might receive are probably your biggest questions.
This guide answers both. You’ll find the 2026 eligibility rules, updated settlement data, what Arnold & Itkin actually does in these cases, and how the filing process works from start to finish.
Arnold & Itkin Roundup Lawsuit: What This Case Is Actually About
The Arnold & Itkin Roundup lawsuit refers to product liability claims filed against Bayer AG for injuries allegedly caused by glyphosate, the active ingredient in Roundup herbicide. Arnold & Itkin LLP, a Houston-based trial firm, represents plaintiffs who developed cancer after using the product.
Roundup has been sold in the United States since 1974. Monsanto originally manufactured it. Bayer bought Monsanto in 2018 for $63 billion and, with it, inherited a growing mountain of litigation.
The International Agency for Research on Cancer classified glyphosate as “probably carcinogenic to humans” in 2015. That classification became the fuel that powered tens of thousands of lawsuits.
Arnold & Itkin entered this litigation as aggressive trial advocates. The firm built its reputation in catastrophic injury and mass tort cases. Their involvement in the Roundup litigation reflects their focus on holding large corporations financially accountable.
| Core Case Facts | Details |
|---|---|
| Defendant | Bayer AG (successor to Monsanto) |
| Active Chemical | Glyphosate |
| Primary Injury Claimed | Non-Hodgkin’s lymphoma |
| Litigation Type | Mass tort / MDL |
| MDL Court | U.S. District Court, N.D. California |
| MDL Number | MDL 2741 |
| Firm Involved | Arnold & Itkin LLP |
Roundup Cancer Lawsuit 2026: Where Things Stand Right Now
The Roundup cancer lawsuit in 2026 is still active, with thousands of cases pending in both state and federal courts. Bayer has paid out billions in settlements already, but tens of thousands of cases remain unresolved.
Bayer attempted to set up a class-action resolution framework in 2021. The U.S. Supreme Court rejected that framework in 2022, sending the company back to the negotiating table. That decision kept individual lawsuits alive and gave plaintiffs more leverage in direct negotiations.
As of 2026, Bayer has reportedly set aside over $16 billion to address Roundup-related claims. New plaintiffs are still being accepted by firms like Arnold & Itkin.
The litigation is not winding down. It is in a sustained resolution phase where individual case merits, diagnosis severity, and exposure history all shape the outcome.
| 2026 Lawsuit Status | Current Position |
|---|---|
| Active Cases | Tens of thousands still pending |
| Bayer Reserve Fund | Approximately $16 billion |
| Class Action Framework | Rejected by U.S. Supreme Court |
| Individual Claims | Still accepted and being filed |
| Trial Verdicts | Multiple plaintiff wins in state courts |
Bayer Roundup Lawsuit Update 2026: The Latest Developments
The biggest Bayer Roundup lawsuit update for 2026 is that individual case resolutions are continuing, and Bayer has not escaped liability through any blanket settlement. Every plaintiff’s case is evaluated separately.
Bayer has won some trials. Plaintiffs have won others. The outcomes depend heavily on the quality of legal representation, the strength of the plaintiff’s medical records, and the exposure evidence presented.
State courts in California, Missouri, and elsewhere have seen substantial plaintiff verdicts. Some verdicts have included punitive damages in the millions. Bayer has appealed many of these results.
In 2025, Bayer signaled it was exploring regulatory clarity as a path to ending the litigation. They pushed for EPA confirmation that glyphosate is safe. That effort has not resolved the litigation. Cases continue moving forward.
Important 2026 update: Federal courts are managing a large backlog. Plaintiffs represented by experienced trial firms like Arnold & Itkin tend to move through the process faster because of the firm’s litigation infrastructure.
Key Takeaway: The Roundup lawsuit in 2026 is active and ongoing. Bayer has not settled all claims, and new plaintiffs are still filing cases with firms like Arnold & Itkin.
Roundup Lawsuit Eligibility: The Basic Requirements
Roundup lawsuit eligibility generally requires two things: documented exposure to Roundup and a qualifying cancer diagnosis. Those two elements form the foundation of every claim.
You don’t need to have used Roundup for decades. Regular use over a period of time, especially occupational exposure, is what matters most. Farmers, landscapers, groundskeepers, and homeowners who used the product regularly are among those who have filed.
The exposure must predate the cancer diagnosis. That sounds obvious, but documentation matters. Purchase receipts, employment records, photographs, or witness statements help establish the timeline.
| Eligibility Factor | What Is Required |
|---|---|
| Roundup Exposure | Regular or occupational use of Roundup |
| Diagnosis Type | Non-Hodgkin’s lymphoma or qualifying cancer |
| Timing | Exposure must predate cancer diagnosis |
| Documentation | Medical records confirming cancer diagnosis |
| Statute of Limitations | Varies by state; generally 2 to 3 years from diagnosis |
A cancer diagnosis alone is not enough. There must be a plausible link between Roundup use and the diagnosis. Your medical records, treatment history, and exposure timeline all factor into case strength.
Who Qualifies for the Roundup Lawsuit in 2026?
People who qualify for the Roundup lawsuit in 2026 are those who used Roundup herbicide and were later diagnosed with non-Hodgkin’s lymphoma or a related blood cancer. That is the core qualifying profile.
Certain occupations carry higher risk and, as a result, stronger cases. These include:
- Farmers and agricultural workers
- Golf course groundskeepers
- Landscapers and lawn care workers
- Nursery and garden center employees
- Homeowners who used Roundup regularly over several years
- Municipal workers who applied herbicide to public spaces
Family members of those who died from qualifying cancers may also be eligible to file wrongful death claims.
Being diagnosed with lymphoma does not automatically guarantee a payout. The claim must show that Roundup exposure was a contributing factor. Arnold & Itkin typically reviews medical records and exposure history before accepting a case.
Quick Note: If you were diagnosed within the last two to three years, time is a factor. Statute of limitations rules vary by state. Acting sooner protects your right to file.
Non-Hodgkin’s Lymphoma Roundup Lawsuit: The Cancer Connection
Non-Hodgkin’s lymphoma is the cancer most closely associated with Roundup exposure in lawsuit claims. It is a cancer of the lymphatic system, which is part of the immune system.
The IARC’s 2015 classification of glyphosate as “probably carcinogenic” was based largely on studies linking the chemical to non-Hodgkin’s lymphoma in humans. That classification was the scientific turning point for this litigation.
There are several subtypes of NHL that have appeared in Roundup lawsuits:
- Diffuse large B-cell lymphoma (DLBCL)
- Follicular lymphoma
- Mantle cell lymphoma
- Small lymphocytic lymphoma
- Chronic lymphocytic leukemia (CLL), which is sometimes treated as NHL
Not all cancers qualify. Roundup cases have primarily focused on lymphomas and some leukemias. Other cancers, like lung cancer or prostate cancer, are generally not accepted in Roundup litigation unless there is a very specific exposure and causation argument.
| Cancer Type | Qualifies for Roundup Lawsuit? |
|---|---|
| Non-Hodgkin’s lymphoma | Yes, primary qualifying cancer |
| Diffuse large B-cell lymphoma | Yes |
| Follicular lymphoma | Yes |
| Mantle cell lymphoma | Yes |
| Chronic lymphocytic leukemia | Sometimes, case-by-case |
| Lung cancer | Generally no |
| Prostate cancer | Generally no |
Key Takeaway: Non-Hodgkin’s lymphoma is the primary qualifying cancer for Roundup lawsuits. The IARC’s 2015 report linking glyphosate to NHL is the scientific backbone of these claims.
Roundup Settlement Amounts 2026: What the Numbers Look Like
Roundup settlement amounts in 2026 vary widely depending on the severity of the diagnosis, the strength of exposure evidence, and whether the case goes to trial or settles in negotiations. There is no single fixed payout.
Bayer’s prior settlements averaged in the range of $160,000 to $200,000 per plaintiff in large resolution packages. But individual trial verdicts have reached into the millions. The gap between the two is significant.
Think of it like the difference between a quick insurance payout and what you’d get if you actually went to court with a strong case. Settling fast often means accepting less. Going to trial carries risk but also potential for much higher awards.
| Payout Category | Estimated Range |
|---|---|
| Low-severity cases (remission, limited exposure) | $25,000 to $100,000 |
| Mid-severity cases (active treatment, moderate exposure) | $100,000 to $250,000 |
| High-severity cases (advanced NHL, extensive exposure) | $250,000 to $500,000+ |
| Trial verdicts (jury awards before appeals) | $1 million to $80 million+ |
| Punitive damages (trial outcomes) | Varies significantly |
These numbers are estimates based on reported settlement data and public court records. Your specific case value depends on factors unique to your situation.
Roundup Lawsuit Payout Per Person: What Actually Affects Your Amount
The Roundup lawsuit payout per person is shaped by several variables that differ from one plaintiff to the next. No two cases pay out the same amount.
The factors that most directly affect your payout include:
- Severity of cancer diagnosis: Advanced or terminal cases typically receive higher compensation
- Duration and frequency of Roundup exposure: Longer, more frequent use supports a stronger causation argument
- Out-of-pocket medical costs: Treatment bills, lost wages, and ongoing care needs factor into damages
- Age at diagnosis: Younger plaintiffs with long projected futures tend to receive higher awards
- Whether the case settles or goes to trial: Trial verdicts can be dramatically higher, but also riskier
- State where the case is filed: Some states have more plaintiff-friendly jury environments
A case that settles quietly for $80,000 might have gone to trial and returned a $3 million verdict. The tradeoff is time, risk, and certainty. Experienced trial firms like Arnold & Itkin typically advise plaintiffs on which path makes more sense given the individual facts.
Arnold & Itkin Roundup Settlement: How the Firm Handles Negotiations
The Arnold & Itkin Roundup settlement approach reflects the firm’s broader reputation as a trial-first law firm. They are known for refusing to accept lowball settlements and preparing every case as if it will go before a jury.
That posture matters in mass tort litigation. Insurance companies and corporate defendants often offer less money to plaintiffs whose attorneys have a reputation for quick settlements. When a firm like Arnold & Itkin is involved, defendants know the case might actually go to trial.
The firm handles settlements on a contingency fee basis. That means clients pay no upfront legal fees. Arnold & Itkin collects a percentage of the final settlement or verdict if the case succeeds.
| Arnold & Itkin Settlement Approach | Details |
|---|---|
| Fee Structure | Contingency (no upfront cost to client) |
| Negotiation Strategy | Trial-ready posture to maximize offers |
| Case Evaluation | Free initial review |
| Client Communication | Dedicated case team, regular updates |
| Settlement Authority | Client retains decision-making power |
The actual negotiation process for a Roundup case can take months to years. Arnold & Itkin manages the legal work, the expert witnesses, and the negotiations. The client’s job is to provide medical records and exposure history.
Key Takeaway: Arnold & Itkin pursues Roundup settlements from a trial-ready position, which typically results in higher settlement offers than firms that default to quick resolutions.
How to File a Roundup Lawsuit in 2026: Step by Step
Filing a Roundup lawsuit in 2026 starts with a free case evaluation with a firm like Arnold & Itkin. You don’t need to gather everything before making that first call. The attorneys will tell you what they need.
Here is how the process generally unfolds:
Step 1: Initial Consultation
You contact the firm. They ask about your Roundup use history and your cancer diagnosis. This call is free and confidential.
Step 2: Medical Record Review
The firm requests your medical records. They look for the cancer diagnosis, the type, the stage, and the treatment timeline.
Step 3: Exposure Documentation
You work with the legal team to document your Roundup use. Receipts, employer records, photos, or witness statements all help.
Step 4: Case Filing
If the firm accepts your case, they file the complaint in the appropriate court. This is where the statute of limitations clock matters most.
Step 5: Discovery and Negotiation
Both sides exchange evidence. Settlement negotiations typically begin here. If no acceptable offer is made, the case may proceed to trial.
Step 6: Resolution
You either settle or take the case to a jury. Your attorney advises you throughout. You make the final call.
The whole process from filing to resolution can take one to three years depending on court scheduling, case complexity, and negotiation outcomes.
Roundup Lawsuit Filing Deadline 2026: Don’t Miss This Window
The Roundup lawsuit filing deadline in 2026 depends on the statute of limitations in your state. Most states give you two to three years from the date of diagnosis or from the date you reasonably discovered the connection between Roundup and your illness.
Missing this deadline means losing your right to sue. No exceptions. No extensions. The statute of limitations is a hard wall.
| State | Statute of Limitations |
|---|---|
| California | 2 years from discovery |
| Texas | 2 years from diagnosis or discovery |
| Missouri | 5 years from discovery |
| Florida | 2 years (recently tightened) |
| Illinois | 2 years from discovery |
| New York | 3 years from discovery |
These are general guidelines. Each case is fact-specific. The “discovery rule” often means the clock starts when you first had reason to know Roundup might have caused your cancer, not necessarily when you were diagnosed.
If you were diagnosed in 2022 or 2023, your window may be closing. Waiting longer than necessary creates real legal risk. Filing now, or at least speaking with a firm now, protects your rights.
Arnold & Itkin Law Firm Roundup Results: Their Track Record
Arnold & Itkin’s Roundup results reflect the firm’s broader record of major verdicts in mass tort and catastrophic injury cases. The firm has secured billions of dollars in verdicts and settlements across its practice areas.
In the Roundup context specifically, Arnold & Itkin has represented plaintiffs at multiple stages of the litigation. Their involvement in cases that reached trial stages helped establish the credibility of glyphosate claims before juries.
The firm’s founding partners, Kurt Arnold and Jason Itkin, built their reputation on trying cases that most firms settle. That philosophy translates directly into how they handle Roundup cases.
Some publicly reported trial results across the Roundup litigation include:
- $289 million verdict in the DeWayne Johnson case (California, 2018, later reduced)
- $80 million verdict in the Edwin Hardeman case (federal court, 2019)
- $2 billion verdict in the Pilliod case (California, 2019, later reduced on appeal)
While Arnold & Itkin may not be lead counsel in every high-profile verdict, the firm participates in this litigation as part of the broader plaintiff attorney community working these cases.
Key Takeaway: Arnold & Itkin brings a trial-first approach to Roundup cases, backed by a broader firm record of major verdicts in product liability and mass tort litigation.
Glyphosate Cancer Lawsuit: The Science Behind the Claims
The glyphosate cancer lawsuit is built on the scientific conclusion that glyphosate, the active ingredient in Roundup, poses a cancer risk to humans. Understanding the science helps you understand why these lawsuits have survived years of corporate defense.
The IARC, a division of the World Health Organization, reviewed available research in 2015. They classified glyphosate as “Group 2A: probably carcinogenic to humans.” That placed it in the same category as red meat and shifts.
The EPA, on the other hand, maintains that glyphosate is not likely carcinogenic at typical exposure levels. That disagreement between agencies is exactly why this litigation is so contentious.
Plaintiffs use the IARC classification and a growing body of epidemiological studies to argue the cancer link. Bayer uses EPA’s position to argue the product is safe when used as directed. Juries have sided with plaintiffs in several high-profile cases.
| Scientific Body | Position on Glyphosate |
|---|---|
| IARC (WHO division) | Probably carcinogenic to humans (Group 2A) |
| EPA (U.S.) | Not likely carcinogenic at typical exposure |
| National Institutes of Health | Some studies show NHL association |
| European Food Safety Authority | Generally considered safe at current levels |
The science is genuinely contested. But courts have found the IARC evidence sufficient to support plaintiff claims in multiple jury trials.
Roundup Weedkiller Cancer Claim: How Exposure Is Established
A Roundup weedkiller cancer claim lives or dies on the ability to prove actual exposure. It’s not enough to say you used Roundup. You have to show how much, how often, and for how long.
Courts and settlement administrators look at exposure in terms of “applicator-days,” meaning how many days you actively applied the product. Higher applicator-days correlate with stronger claims.
Ways to establish your exposure history:
- Employment records: If you used Roundup as part of a job, employer records and payroll documents can confirm duration and role
- Purchase history: Store receipts, loyalty card records, or Amazon purchase history showing Roundup purchases
- Property records: Records showing you maintained large property areas where herbicide use was necessary
- Witness testimony: Neighbors, coworkers, or family members who observed your Roundup use
- Medical expert opinion: A doctor who can link your exposure level to your diagnosis
If you used Roundup casually once or twice, your claim is likely weaker. But if you sprayed your fields every spring and summer for ten years, that’s a very different conversation.
Roundup Lawsuit Status 2026: Is It Too Late to File?
The Roundup lawsuit status in 2026 confirms that new claims are still being accepted. The litigation is not closed. Bayer has not reached a global settlement that would bar individual claims.
This is an important point. Some people assume that because these lawsuits started years ago, the window has closed. That’s not accurate. New plaintiffs are being added to the litigation regularly.
What has changed is the landscape for future plaintiffs. Bayer has been more aggressive about early resolution of individual cases. And courts have become more efficient at moving cases through the system.
If you have not filed yet but believe you have a valid claim, 2026 is still a viable year to take action. The risk is waiting. Each year that passes brings more statute of limitations risk and more potential difficulty in gathering evidence.
Current status snapshot for 2026:
- Tens of thousands of cases still pending resolution
- Individual trials continuing in state courts
- Federal MDL cases being resolved through negotiated packages
- New plaintiff intakes open at Arnold & Itkin and other firms
- Bayer still facing active litigation, no global resolution reached
Key Takeaway: As of 2026, the Roundup lawsuit is still open for new plaintiffs. The key risk is waiting too long and triggering the statute of limitations in your state.
Arnold & Itkin Mass Tort Experience: Why It Matters for Your Case
Arnold & Itkin’s mass tort experience is a key reason why plaintiffs in complex cases like Roundup seek out the firm specifically. Mass torts are not like regular personal injury cases. They require different infrastructure, different resources, and a different legal strategy.
In a typical car accident case, one attorney might handle everything. In a mass tort like the Roundup litigation, there are thousands of plaintiffs, hundreds of attorneys, mountains of scientific evidence, and corporate defendants with unlimited legal budgets.
Arnold & Itkin has handled major mass tort cases across multiple industries. Their work in the Deepwater Horizon disaster, maritime injury cases, and other large-scale litigation gave them the operational capacity to manage complex plaintiff-side litigation at scale.
What that means for a Roundup plaintiff working with this firm:
- Dedicated case teams rather than solo attorneys
- In-house capacity for expert witness coordination
- Trial preparation built into every case from day one
- Direct partner involvement in major case decisions
- Resources to go to trial if settlement offers are inadequate
Mass tort litigation can feel impersonal because of the volume of cases. Arnold & Itkin’s structure is built to address that. Every case still requires individual attention because individual facts drive individual outcomes.
| Arnold & Itkin Mass Tort Capabilities | Why It Matters |
|---|---|
| Dedicated litigation teams | Faster case movement, consistent communication |
| Expert witness network | Stronger causation arguments in court |
| Trial infrastructure | Credible threat of trial improves settlement offers |
| Contingency fee model | No financial risk to clients |
| Multi-state filing capacity | Can file in the optimal jurisdiction for each plaintiff |
Frequently Asked Questions
What does Arnold & Itkin do in Roundup lawsuits?
Arnold & Itkin represents plaintiffs who developed cancer after using Roundup and seeks compensation from Bayer AG on their behalf.
The firm handles case intake, medical record review, exposure documentation, negotiations, and trial preparation.
They work on a contingency fee basis, meaning clients pay nothing unless the case results in a settlement or verdict.
How much can I get from a Roundup lawsuit settlement in 2026?
Settlement amounts in 2026 range widely, from around $25,000 for minor cases to over $250,000 for severe diagnoses.
Trial verdicts in state courts have reached into the millions, though appeals often reduce those amounts.
Your specific payout depends on cancer severity, exposure history, medical costs, and whether your case settles or goes to trial.
Who qualifies for the Roundup cancer lawsuit?
People who qualify are those who regularly used Roundup and were later diagnosed with non-Hodgkin’s lymphoma or a related blood cancer.
Farmers, landscapers, groundskeepers, and homeowners who used the product frequently are the most common qualifying plaintiffs.
Family members of those who died from qualifying cancers may file wrongful death claims.
What is the filing deadline for the Roundup lawsuit in 2026?
The filing deadline depends on your state’s statute of limitations, which is typically two to three years from diagnosis or discovery.
Missing this deadline permanently bars your right to sue, with no exceptions.
If you were diagnosed in 2022, 2023, or 2024, your deadline may already be approaching or could have passed in some states.
What type of cancer is linked to Roundup exposure?
Non-Hodgkin’s lymphoma is the cancer most closely linked to Roundup exposure in both scientific research and litigation.
Subtypes like diffuse large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma are all accepted qualifying diagnoses.
Other cancers, like lung or prostate cancer, are generally not accepted in Roundup claims without very specific causation evidence.
What You Should Do Right Now
The Roundup litigation is real, ongoing, and still producing results for plaintiffs in 2026. If you used Roundup regularly and received a cancer diagnosis, you likely have a case worth evaluating.
Time is the one thing you can’t get back in this process. Every day closer to the statute of limitations deadline is a day of risk.
Start with a free case evaluation. Gather your medical records and any documentation of your Roundup use. An attorney can tell you quickly whether your case qualifies. From there, the legal team does the heavy lifting.
